Barbara Rentroia‐Pacheco

Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model

Alexander M.M. Eggermont, Domenico Bellomo, Suzette M. Arias‐Mejias et al. · European Journal of Cancer · 2020 · 48 citations · Full text

Tumor Biology, Disease Relapse, Oncology +12

Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study

Ahmed Yousaf, Félicia Tjien-Fooh, Barbara Rentroia‐Pacheco et al. · International Journal of Dermatology · 2021 · 38 citations · Full text

Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary

Iva Johansson, Dennie Tempel, Jvalini Dwarkasing et al. · European Journal of Surgical Oncology · 2021 · 34 citations · Full text

Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model

Barbara Rentroia‐Pacheco, Selin Tokez, Edo M. Bramer et al. · EClinicalMedicine · 2023 · 26 citations · Full text

Trypanosoma brucei triggers a broad immune response in the adipose tissue

Henrique Machado, Tiago Bizarra-Rebelo, Mariana Sequeira et al. · PLoS Pathogens · 2021 · 25 citations · Full text